Medco Energi Internasional will focus on developing conventional energy
Prices and demand for alternative energy are still unstable. This condition encourages PT Medco Energi Internasional Tbk (MEDC) to re-focus on conventional energy sources, namely oil and gas (oil and gas).
MEDC will soon release the participating interest of coal bed methane (CBM) production blocks one by one. "CBM is low priority, we will focus on conventional energy," said Ronald Gunawan, Director of Operations MEDC last weekend (18/6).
MEDC has three blocks of CBM production, namely Sekayu Block, Lematang Block and Muralim Block, which are all located in South Sumatra. One of the most visible blocks; The release scheme is the Lematang Block. In this block, MEDC owns 80%, PT Saka Energi 5% and PT Methanindo Energy Reseources 15%.
The participating interest sales process begins in December 2014. MEDC signed a sale and purchase agreement (ASPA) with Methanindo. MEDC will release 21% participating interest to Methanindo. As compensation, Methanindo is required to pay US $ 555,666 or at least equivalent to Rp 70 billion to MEDC.
In November 2016, MEDC awarded the remaining 34% participating interest to Methanindo. This transfer of rights of participation does not get the approval of the government.
MEDC is also negotiating to release Sekayu Block. In this block, MEDC through its subsidiary, PT Medco CBM Sekayu in partnership with South Sumatra Energy Inc. (SSE Inc). Each gets a 50% participating interest. Medco becomes an operator on this block.
MEDC has a 50% participating interest in Muralim Block with Dart Energy acting as operator. "If the Muralim block is still maintained," added Ronald.
MEDC owner Arifin Panigoro said the company is continuing to process the purchase of contractor shares as well as listed companies in the Australian stock exchange, namely Macmahon Holdings Limited. Medco has processed a preliminary agreement or head of agreement (HOA) related to the purchase of shares. "In essence, we want to invite them in," said Arifin.
The acquisition plan began with the publication of 954 million new shares of Macmahon worth A $ 0.203 per share. These shares will be absorbed by the grandson of MEDC, Amman Minerals Contractors Pte Ltd (AMC). AMC will hold a 44.3% stake in Macmahon. Currently, 65% of AMC's shares are held by PT Amman Mineral Nusa Tenggara, and the rest is by PT AP Investment.
This Congress will have the right to mine blocks, namely Batu Hijau Block, Elang Block and Nangka Block. Macmahon needs to ask shareholder approval regarding this plan next month.
Muhammad Nafan Aji, an analyst at Binaartha Parama Sekuritas, said the issuers should strive to improve performance, including through efficiency. The release of assets can make MEDC more quick to find other energy alternatives.
"With a focus on developing South Natuna Sea Block B, it is expected that the issuer's prospects will grow," he added. Nafan predicts, MEDC revenue this year potentially rose 4% to US $ 624 million. He recommends buying MEDC with a target of Rp 3,400
IN INDONESIA
Medco Melepas Asset CBM Secara Bertahap
Medco Energi Internasional akan fokus pada pengembangan energi konvensional
Harga dan permintaan energi alternatif masih belum stabil. Kondisi ini mendorong PT Medco Energi Internasional Tbk (MEDC) kembali fokus pada sumber energi konvensional, yakni minyak dan gas (migas).
MEDC akan segera melepas hak partisipasi (participating interest) blok produksi gas metana batubara atau coal bed methane (CBM) satu per satu. "CBM itu low priority, kami akan fokus pada energi konvensional," ujar Ronald Gunawan, Direktur Operasi MEDC akhir pekan lalu (18/6).
MEDC punya tiga blok produksi CBM, yakni Blok Sekayu, Blok Lematang dan Blok Muralim, yang seluruhnya berada di Sumatra Selatan. Salah satu blok yang paling terlihat; skema pelepasannya adalah Blok Lematang. Di blok ini, MEDC memiliki kepemilikan 80%, PT Saka Energi sebesar 5% dan PT Methanindo Energi Reseources 15%.
Proses penjualan participating interest dimulai Desember 2014. MEDC menandatangani asset sale and purchase agreement (ASPA) dengan Methanindo. MEDC akan melepas 21% participating interest kepada Methanindo. Sebagai kompensasi, Methanindo wajib membayar US$ 555.666 atau setidaknya setara Rp 70 miliar ke MEDC.
Pada November 2016, MEDC menyerahkan sisa 34% participating interest kepada Methanindo. Pengalihan hak partisipasi ini tidak kunjung memperoleh persetujuan dari pemerintah.
MEDC juga sedang bernegosiasi melepas Blok Sekayu. Di blok ini, MEDC melalui anak usahanya, PT Medco CBM Sekayu bermitra dengan South Sumatra Energy Inc (SSE Inc). Masing-masing mendapatkan participating interest 50%. Medco menjadi operator di blok ini.
MEDC memiliki participating interest 50% di Blok Muralim bersama Dart Energy yang bertindak sebagai operator. "Kalau yang blok Muralim masih kami pertahankan," imbuh Ronald.
Pemilik MEDC Arifin Panigoro mengatakan, pihaknya terus melanjutkan proses transaksi pembelian saham kontraktor sekaligus perusahaan yang tercatat di bursa Australia, yakni Macmahon Holdings Limited. Medco telah memproses perjanjian awal atau head of agreement (HOA) terkait pembelian saham. "Intinya, kami ingin mengajak mereka masuk," ujar Arifin.
Rencana akuisisi ini diawali dengan penerbitan 954 juta saham baru Macmahon senilai A$ 0,203 per saham. Saham ini akan diserap oleh cucu usaha MEDC, Amman Mineral Contractors Pte Ltd (AMC). AMC akan menggenggam 44,3% saham Macmahon. Saat ini, 65% saham AMC dipegang oleh PT Amman Mineral Nusa Tenggara, dan sisanya oleh PT AP Investment.
Kongsi ini nantinya akan memiliki hak untuk menambang sejumlah blok, yakni Blok Batu Hijau, Blok Elang dan Blok Nangka. Macmahon perlu meminta restu pemegang saham terkait rencana ini pada bulan depan.
Muhammad Nafan Aji, analis Binaartha Parama Sekuritas menyebut, emiten harus berupaya meningkatkan kinerja, termasuk lewat efisiensi. Pelepasan aset bisa membuat MEDC lebih cepat mencari alternatif energi lain.
"Dengan fokus pada pengembangan South Natuna Sea Block B, diharapkan prospek emiten ini bisa berkembang," tambah dia. Nafan memprediksi, pendapatan MEDC tahun ini berpotensi naik 4% menjadi US$ 624 juta. Dia merekomendasikan buy MEDC dengan target Rp 3.400.
Kontan, Page-4, Monday, June 19, 2017
No comments:
Post a Comment